BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8775462)

  • 1. Binding domain regulation of MHC class II molecule assembly, trafficking, fate, and function.
    Germain RN
    Semin Immunol; 1995 Dec; 7(6):361-72. PubMed ID: 8775462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC II and the endocytic pathway: regulation by invariant chain.
    Landsverk OJ; Bakke O; Gregers TF
    Scand J Immunol; 2009 Sep; 70(3):184-93. PubMed ID: 19703008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular organelles involved in antigen processing and the binding of peptides to class II MHC molecules.
    Harding CV
    Semin Immunol; 1995 Dec; 7(6):355-60. PubMed ID: 8775461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
    Cheng PC; Steele CR; Gu L; Song W; Pierce SK
    J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments.
    Anderson HA; Bergstralh DT; Kawamura T; Blauvelt A; Roche PA
    J Immunol; 1999 Nov; 163(10):5435-43. PubMed ID: 10553069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.
    Lautwein A; Kraus M; Reich M; Burster T; Brandenburg J; Overkleeft HS; Schwarz G; Kammer W; Weber E; Kalbacher H; Nordheim A; Driessen C
    J Leukoc Biol; 2004 May; 75(5):844-55. PubMed ID: 14966190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invariant chain can bind MHC class II at a site other than the peptide binding groove.
    Wilson NA; Wolf P; Ploegh H; Ignatowicz L; Kappler J; Marrack P
    J Immunol; 1998 Nov; 161(9):4777-84. PubMed ID: 9794409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
    Mukherjee R; Chaturvedi P; Lee-Chan E; Singh B
    Mol Immunol; 2008 Apr; 45(8):2166-76. PubMed ID: 18279957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation regulates the delivery of MHC class II invariant chain complexes to antigen processing compartments.
    Anderson HA; Roche PA
    J Immunol; 1998 May; 160(10):4850-8. PubMed ID: 9590232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
    Thayer WP; Ignatowicz L; Weber DA; Jensen PE
    J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MHC class II-associated invariant chain: a molecule with multiple roles in MHC class II biosynthesis and antigen presentation to CD4+ T cells.
    Bertolino P; Rabourdin-Combe C
    Crit Rev Immunol; 1996; 16(4):359-79. PubMed ID: 8954255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The function of invariant chain in class II-restricted antigen presentation.
    Ceman S; Sant AJ
    Semin Immunol; 1995 Dec; 7(6):373-87. PubMed ID: 8775463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
    Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
    Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.
    Busch R; Doebele RC; von Scheven E; Fahrni J; Mellins ED
    J Immunol; 1998 Jan; 160(2):734-43. PubMed ID: 9551909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
    Watts C
    Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
    Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
    J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules.
    Kang SJ; Cresswell P
    EMBO J; 2002 Apr; 21(7):1650-60. PubMed ID: 11927549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding.
    Germain RN; Hendrix LR
    Nature; 1991 Sep; 353(6340):134-9. PubMed ID: 1891045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembly and transport of major histocompatibility complex molecules.
    Teyton L
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S33-6. PubMed ID: 7909942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.